1968/01/01 by George Markousis‐Mavrogenis, Jasper Tromp, Wouter Ouwerkerk +19 · 1 voice · 1 citation
Engineering · Immunology and Microbiology · Medicine · #Cardiac Fibrosis and Remodeling #Electric Power Systems and Control #Heart Failure Treatment and Management #IL-33, ST2, and ILC Pathways
paper · pdf · doi:10.1002/ejhf.1482
openalex publication_date 1968/01/01 · openalex created_date 2016/06/24 · openalex updated_date 2026/08/01
In a large, heterogeneous cohort of HF patients, elevated IL-6 levels were found in more than 50% of patients and were associated with iron deficiency, reduced LVEF, atrial fibrillation and poorer clinical outcomes. These findings warrant further investigation of IL-6 as a potential therapeutic target in specific HF subpopulations.